The strength of the anti-addictive effect of GLP-1s appears so clear that many physicians are already using these treatments for patients with substance use disorders (SUD)
Trials are expanding data on the benefits of GLP-1s in chronic kidney disease and heart failure with preserved ejection fraction (HFpEF)
chemokines and cytokines, and neuropeptides ( Due to the efficacy of GLP-1 upon blood glucose regulation, DPP-4i has gradually become a new anti-diabetic drug for the treatment of type 2 diabetes mellitus (T2DM)
Semaglutide reduces A1c by 1.0 to 1.5 percentage points on average
Table of Contents Retatrutide in Pakistan In a country like Pakistan, where obesity and diabetes are rising at alarming rates, theres a growing demand for safe, effective, and science-backed solutions
Think of this as metabolic psychiatry addressing the whole person